Back
Cocrystal Pharma Vs. Cara Therapeutics Industry Stock Comparison
Buy
51
COCP
Cocrystal Pharma
Last Price:
1.81
Seasonality Move:
-16.23%
Sell
11
CARA
Cara Therapeutics
Last Price:
0.30
Seasonality Move:
-11.19%
Buy
51
Cocrystal Pharma (COCP)
is a Buy
Is Cocrystal Pharma a Buy, Sell or Hold?
- The current Cocrystal Pharma [COCP] share price is $1.83. The Score for COCP is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
- COCP is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
11
Cara Therapeutics (CARA)
is a Sell
Is Cara Therapeutics a Buy, Sell or Hold?
- The current Cara Therapeutics [CARA] share price is $0.29. The Score for CARA is 11, which is 78% below its historic median score of 50, and infers higher risk than normal.
- CARA is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
COCP Stock Price Chart
What is Cocrystal Pharma's stock price today?
-
The Cocrystal Pharma share price today is $1.83
The current trend is relatively stagnant and COCP is experiencing buying pressure, which is a positive indicator for future bullish movement.
CARA Stock Price Chart
What is Cara Therapeutics's stock price today?
-
The Cara Therapeutics share price today is $0.29
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CARA is experiencing selling pressure, which indicates risk of future bearish movement.
COCP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.04 | Sell |
| Relative Strength Index (14 RSI): | 52.14 | Buy |
| Chaikin Money Flow: | 6184 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.69 - 1.91) | Buy |
| Bollinger Bands (100): | (1.72 - 2.38) | Sell |
CARA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.02 | Sell |
| Relative Strength Index (14 RSI): | 43.76 | Sell |
| Chaikin Money Flow: | -366348 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.29 - 0.35) | Sell |
| Bollinger Bands (100): | (0.26 - 0.64) | Sell |
COCP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.73 | Buy |
| 20-day SMA: | 1.76 | Buy |
| 50-day SMA: | 1.91 | Sell |
| 200-day SMA: | 1.82 | Buy |
| 8-day EMA: | 1.76 | Buy |
| 20-day EMA: | 1.77 | Buy |
| 50-day EMA: | 1.88 | Sell |
| 200-day EMA: | 1.96 | Sell |
CARA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.28 | Buy |
| 20-day SMA: | 0.31 | Sell |
| 50-day SMA: | 0.33 | Sell |
| 200-day SMA: | 0.61 | Sell |
| 8-day EMA: | 0.29 | Buy |
| 20-day EMA: | 0.31 | Sell |
| 50-day EMA: | 0.35 | Sell |
| 200-day EMA: | 0.92 | Sell |
Cocrystal Pharma Earnings Growth & COCP Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.08 per share, an increase next quarter of $0.02 per share, an increase this year of $0.15 per share, and a decrease next year of $0.27 per share.
Cara Therapeutics Earnings Growth & CARA Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.25 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.71 per share, and an increase next year of $0.52 per share.
Cocrystal Pharma Technical Analysis
| Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Cara Therapeutics Technical Analysis
| Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||